Evidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients

被引：35
|
作者：
Margiotti, K
Sangiuolo, F
De Luca, A
Froio, F
Pearce, CL
Ricci-Barbini, V
Micali, F
Bonafè, M
Franceschi, C
Dallapiccola, B
Novelli, G
Reichardt, JKV
机构：
[1] Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, I-00133 Rome, Italy
[2] USC, Keck Sch Med, Dept Biochem & Mol Biol, Inst Med Genet, Los Angeles, CA USA
[3] Osped Villa San Pietro, Serv Patol Clin, Rome, Italy
[4] USC, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA USA
[5] Osped CSS, IRCCS, Div Urol, San Giovanni Rotondo, Italy
[6] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy
[7] Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, Rome, Italy
[8] CSS Mendel Inst, Rome, Italy
来源：
DISEASE MARKERS | 2000年 / 16卷 / 3-4期
关键词：
prostate cancer; SRD5A2; gene; prostate cancer risk; polymorphic variant;
D O I：
10.1155/2000/683607
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
We have investigated the contributions of three polymorphic markers in the SRD5A2 gene to prostate cancer in a group of Italian patients. We have genotyped cases and controls for a polymorphic (TA), dinucleotide repeat and two functional substitutions, A49T and V89L, substituting respectively alanine with threonine at codon 49, and valine to leucine at codon 89, We found a substantially increased but not significant risk associated with the 49T mutation and a reduction of risk for the V89L substitution. In conclusion, we report on preliminary evidence for both increased and decreased risk associated with separate markers at this locus.
引用
收藏
页码：147 / 150
页数：4
相关论文
共 50 条
  • [1] Associations between polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JK
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 374 - 374
  • [2] Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
    Salam, MT
    Ursin, G
    Skinner, EC
    Dessissa, T
    Reichardt, JKV
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2005, 23 (04) : 246 - 253
  • [3] Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5α-reductase during prostate cancer progression
    Akalu, A
    Elmajian, DA
    Highshaw, RA
    Nichols, PW
    Reichardt, JKV
    [J]. JOURNAL OF UROLOGY, 1999, 161 (04): : 1355 - 1358
  • [4] Association among polymorphisms in the steroid 5α-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population
    Paz-y-Mino, Cesar
    Witte, Tania
    Robles, Paulo
    Llumipanta, William
    Diaz, Myriam
    Arevalo, Melissa
    [J]. CANCER GENETICS AND CYTOGENETICS, 2009, 189 (02) : 71 - 76
  • [5] Association of 5-alpha-reductase gene (SRD5A2) with prostate cancer.
    Mononen, N
    Koivisto, PA
    Ikonen, T
    Syrjäkoski, K
    Schleutker, J
    Hyytinen, E
    Tammela, TLJ
    Kallioniemi, OP
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 95 - 95
  • [6] Steroid 5-α-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review
    Li, Jun
    Coates, Ralph J.
    Gwinn, Marta
    Khoury, Muin J.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (01) : 1 - 13
  • [7] The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
    Choi, Se Young
    Kim, Hae Jong
    Cheong, Hyun Sub
    Myung, Soon Chul
    [J]. KOREAN JOURNAL OF UROLOGY, 2015, 56 (01) : 19 - 29
  • [8] Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissue
    Nick Makridakis
    Abebe Akalu
    Juergen K V Reichardt
    [J]. Oncogene, 2004, 23 : 7399 - 7405
  • [9] Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissue
    Makridakis, N
    Akalu, A
    Reichardt, JKV
    [J]. ONCOGENE, 2004, 23 (44) : 7399 - 7405
  • [10] POLYMORPHISMS OF HPC2/ELAC2 AND SRD5A2 (5α-Reductase Type II) GENES IN PROSTATE CANCER
    Izmirli, M.
    Arikan, B.
    Bayazit, Y.
    Alptekin, D.
    [J]. BALKAN JOURNAL OF MEDICAL GENETICS, 2011, 14 (01) : 31 - 35
12345